Oculus Pathology announced today that it is now providing laboratory and diagnostic pathology services to physician practices, clinics, and ambulatory surgery centers across the Phoenix metropolitan area, expanding access to physician-led, subspecialty pathology support in one of the nation’s fastest-growing healthcare markets.

Phoenix’s continued population growth and expanding outpatient footprint have increased demand for pathology partners that can deliver consistent turnaround times, subspecialty depth, and operational reliability without disrupting established clinical workflows. Oculus Pathology enters the market with more than seven decades of experience supporting both hospital-based and outpatient care environments nationwide.

Founded in 1948, Oculus Pathology is a physician-led laboratory organization providing anatomic and clinical pathology services with a focus on diagnostic accuracy, clinical correlation, and long-term partnership. The organization supports high-volume practices and ASCs with subspecialty expertise typically found in academic settings, paired with the responsiveness and flexibility required in private practice environments.

“The Phoenix market is sophisticated, fast-moving, and growing,” said Matt Thompson, CEO of Oculus Pathology. “Practices here need pathology support that can scale with them while remaining clinically engaged and dependable day to day. Our model is built for that reality.”

Oculus Pathology’s physician team includes more than 40 board-certified pathologists across a wide range of specialties, including dermatopathology, gastrointestinal pathology, gynecologic pathology, urologic pathology, hematopathology, neuropathology, pediatric pathology, renal pathology, cytopathology, and head and neck pathology. Services are delivered through standardized processes, advanced diagnostic capabilities, and a consultative approach designed to integrate smoothly with existing clinical operations.

The laboratory is CLIA-certified and accredited by the College of American Pathologists, supporting consistent quality standards and regulatory compliance across all service lines.

“Pathology should never feel like a black box for clinicians,” said Edward Weir, M.D., president of the board of directors for Oculus Pathology. “Our focus is transparency, availability, and accountability. As Phoenix practices grow, we’re here to support that growth with reliable diagnostics and a partnership mindset.”

Oculus Pathology is actively connecting with physician leaders and surgery centers throughout the Phoenix area to introduce its services and evaluate collaboration opportunities.

For additional information about pathology services available in Phoenix, visit https://thinkoculus.com/Phoenix.